Skip to content

Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery

Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06519500
Enrollment
40
Registered
2024-07-25
Start date
2023-03-03
Completion date
2026-11-03
Last updated
2024-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastro-entero-pancreatic Neoplasms

Brief summary

Observational, prospective, feasibility pilot study of the preparation of organoids starting from tumor tissue and surrounding healthy tissue, collected during surgery, performed according to standard clinical practice.

Detailed description

Given the need for the use of experimental models that mimic the tumor of origin

Interventions

None listed

Sponsors

Regina Elena Cancer Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* over 18 years of age; * diagnosis of GEP-NEN carried out via histological investigation or via positivity to the uptake PET-CT with 68Ga-peptides; * availability of adequate material for the preparation of organoid cultures, derived from surgery; * written informed consent.

Exclusion criteria

* previous chemotherapy treatments

Design outcomes

Primary

MeasureTime frameDescription
Set up of at least 10 organoid cultures42 monthsThe organoids will be generated from tumor tissue samples and surrounding healthy tissue obtained from patients affected by GEP-NEN (who meet the inclusion/exclusion criteria) collected, according to clinical practice, during tumor resection surgery. Only the excess material after carrying out all the investigations necessary for the correct diagnosis histological analysis can be used for the purpose of the project

Countries

Italy

Contacts

Primary ContactLaura Monteonofrio, Doctor
laura.monteonofrio@ifo.it0652665270

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026